News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients
Friday, November 18, 2022TJP Labs Inc is North Americas leading fullservice contract manufacturer of premier nextgeneration products focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products Today TJP Labs announced th...
Mindset Pharma and PharmAla Enter into Exclusive Sales Agreement for the Sale and Distribution of Pharmaceutical Grade Psilocybin
Thursday, November 17, 2022Mindset Pharma Inc a drug discovery company developing novel optimized nextgeneration psychedelic and nonpsychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs and PharmAla Biotech Holdings Inc a biotech...
Skye Bioscience Initiates First-in-Human Phase 1 Clinical Trial for SBI-100
Thursday, November 17, 2022Skye Bioscience Inc a pharmaceutical company developing a proprietary synthetic cannabinoid derivative to treat glaucoma has initiated screening for its firstinhuman Phase trial of SBI Ophthalmic Emulsion SBI OE As previously announced this study ha...
Chain Pharmaceuticals GmbH Announces Its Phytocannabinoid Drug Discovery Platform
Wednesday, November 16, 2022Dr Pierre Debs PhD announced today the launch of Chain Pharmaceuticals GmbH a phytocannabinoid drug discovery company leveraging machine learning and real world
ZYUS Announces Database Lock for its Phase 1 First-in-Human Clinical Trial
Wednesday, November 16, 2022ZYUS Life Sciences Inc a Canadianbased life sciences company leading scientific research and global development of innovative cannabinoidbased pharmaceutical drug products today announced the successful completion of database lock for its Phase clin...
Ono Pharmaceutical and Captor Therapeutics Announce Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
Tuesday, November 15, 2022Captor Therapeutics SA a leader in the development of Targeted Protein Degradation TPDbased drugs today announces a worldwide drug discovery collaboration with Ono Pharmaceutical Co Ltd
Indivior To Acquire Opiant Pharmaceuticals
Tuesday, November 15, 2022Indivior PLC and Opiant Pharmaceuticals Inc announced that the companies have entered into a definitive agreement under which Indivior will acquire Opiant for an upfront consideration of per share in cash approximately million in aggregate plus up...
Lytix Biopharma announces expansion of the ATLAS-IT-05 study to Europe
Monday, November 14, 2022Lytix Biopharma a Norwegian immunooncology company today announces site activation for the ATLASIT study in three European countries ATLASIT is a Phase II combination study evaluating LTX and pembrolizumab in patients with advanced melanoma The study...
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
Friday, November 11, 2022BeiGene a global biotechnology today announced BRUKINSA zanubrutinib has been approved in Brazil for the treatment of adult patients with Waldenstrms macroglobulinemia WM and adult patients with relapsedrefractory RR marginal zone lymphoma MZL who ha...
Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
Friday, November 11, 2022Scipher Medicine announced data validating the clinical utility of the companys PrismRA test for guiding treatment selection for rheumatoid arthritis RA patients The latest publication in the Expert Review of Molecular Diagnostics showed that patient...
